What does PureTech invest in?
PureTech invests most often at Series A and Series B (67% of the rounds on record).
Last cheque observed Mar 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
3 rounds on record
Mostly Series A and Series B: 67% of its rounds
Every round we can evidence, newest first3 appearances
1 round
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as PureTech. A count of rooms they were both in, not a relationship either has claimed.
The latest companies PureTech put money into.
PureTech invests most often at Series A and Series B (67% of the rounds on record).
3 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2019.
Its most recent investments on record: Karuna Therapeutics (Series B, Mar 2019), Vedanta Biosciences (Series C, Dec 2018) and Karuna Pharma (Series A, Aug 2018).
The median round it joins is $42M.
No investments in the last 12 months; the latest was in Mar 2019.
Most often Wellcome Trust (2 rounds together).
PureTech is a growth equity firm.
From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it